Contact Us

2215 Auto Park Lane
Escondido, California 92026
United States
PR Agency Contact
Kimberly Easton
CEO
KEI Connects
917-678-6411
Kimberly@KEIConnects.com
Company Contact
Christopher Hussey
Communications Director
816-400-9670
christopher@isodiol.com

More »

Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the "Company" or "Isodiol"), a global innovator specializing in the development of pharmaceutical and wellness products and is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products. Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products. Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.www.isodiolinternational-com.isodiolinternational.com

COMPANY MEDIA:
Isodiol.com 
Iso-sport.com 
Potocoffee.coffee 
BeTru Organics 
C3 Global Biosciences 
Join Us On Facebook: https://www.facebook.com/Isodiol/ 
Twitter: @isodiol

News Releases
Jun 1, 2018

NEW YORK, June 1, 2018 -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the "Company" or "Isodiol"), a global Bioactive CBD innovator, specializing in the development of...

May 31, 2018

(May 30, 2018) – -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of...

More »